Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System Lymphoma
Clinical trial NCT05135858 · UNKNOWN
Trial details
- NCT number
- NCT05135858
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-15
- Primary completion
- 2025-01-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.